Repertoire Partners LP Buys 129,707 Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS)

Repertoire Partners LP boosted its stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 83.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 284,707 shares of the company's stock after acquiring an additional 129,707 shares during the quarter. Integral Ad Science accounts for 1.2% of Repertoire Partners LP's portfolio, making the stock its 5th largest position. Repertoire Partners LP owned about 0.18% of Integral Ad Science worth $2,972,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Integral Ad Science by 42.7% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 155,010 shares of the company's stock worth $1,618,000 after acquiring an additional 46,395 shares during the last quarter. State of Wyoming bought a new position in Integral Ad Science in the 4th quarter worth approximately $51,000. Sherbrooke Park Advisers LLC acquired a new stake in shares of Integral Ad Science in the 4th quarter valued at $132,000. ProShare Advisors LLC raised its position in shares of Integral Ad Science by 50.5% during the fourth quarter. ProShare Advisors LLC now owns 20,556 shares of the company's stock worth $215,000 after acquiring an additional 6,900 shares during the last quarter. Finally, Nuveen Asset Management LLC lifted its stake in shares of Integral Ad Science by 0.8% during the fourth quarter. Nuveen Asset Management LLC now owns 1,920,523 shares of the company's stock valued at $20,050,000 after acquiring an additional 15,432 shares during the period. 95.78% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Barclays boosted their price objective on Integral Ad Science from $7.00 to $9.00 and gave the stock an "equal weight" rating in a report on Tuesday, May 13th. Raymond James increased their price objective on shares of Integral Ad Science from $11.00 to $13.00 and gave the company an "outperform" rating in a report on Tuesday, May 13th. Truist Financial lifted their target price on shares of Integral Ad Science from $16.00 to $17.00 and gave the stock a "buy" rating in a report on Monday, March 3rd. Morgan Stanley dropped their target price on shares of Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Finally, Scotiabank assumed coverage on Integral Ad Science in a research report on Friday, February 28th. They issued a "sector perform" rating and a $12.00 price target on the stock. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $13.55.

Insider Activity

In other Integral Ad Science news, CEO Lisa Utzschneider sold 8,547 shares of the company's stock in a transaction on Monday, April 7th. The shares were sold at an average price of $6.85, for a total transaction of $58,546.95. Following the sale, the chief executive officer now directly owns 341,271 shares of the company's stock, valued at approximately $2,337,706.35. This represents a 2.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders sold 86,222 shares of company stock worth $636,252 in the last quarter. Corporate insiders own 2.00% of the company's stock.

Integral Ad Science Trading Up 0.6%

NASDAQ IAS opened at $8.13 on Wednesday. Integral Ad Science Holding Corp. has a one year low of $6.26 and a one year high of $13.62. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. The firm has a market cap of $1.34 billion, a P/E ratio of 40.65, a P/E/G ratio of 1.06 and a beta of 1.55. The stock's 50-day moving average is $7.62 and its 200-day moving average is $9.57.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.03 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm had revenue of $134.07 million for the quarter, compared to analyst estimates of $129.20 million. Sell-side analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Want to see what other hedge funds are holding IAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.